Table 5 Average cost and QALY of chemotherapy regimens
STATE | AREA | COST ($) | QALY | |
|---|---|---|---|---|
FOLFOX | ||||
Progression-Free State | 6.9 | 1988.15 | 0.45 | |
Post-Progression State | 6.35 | 1010.33 | 0.29 | |
(Dead) | 46.75 | |||
Total | 60 | 2998.48 | 0.75 | |
FOLFOX + TRASTUZUMAB | ||||
Progression-Free State | 9 | 5677.07 | 0.59 | |
Post-Progression State | 7.25 | 1481.76 | 0.33 | |
(Dead) | 43.74 | |||
Total | 60 | 7158.83 | 0.92 | |
CAPOX | ||||
Progression-Free State | 6.9 | 1835.15 | 0.45 | |
Post-Progression State | 6.35 | 975.96 | 0.29 | |
(Dead) | 46.75 | |||
Total | 60 | 2811.11 | 0.75 | |
CAPOX + TRASTUZUMAB | ||||
Progression-Free State | 9 | 4765.34 | 0.59 | |
Post-Progression State | 7.25 | 1362.63 | 0.33 | |
(Dead) | 43.74 | |||
Total | 60 | 6127.98 | 0.92 |